Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies

Clinical trial NCT05513612 · WITHDRAWN

Trial details

NCT number: NCT05513612
Sponsor: Shanghai Pudong Hospital
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)B-cell Non-Hodgkin's Lymphoma (B-NHL)Multiple Myeloma (MM)T-Cell Leukemia/Lymphoma, Adult B-cell Acute Lymphoblastic Leukemia (B-ALL)

Start date: 2020-08-01
Primary completion: 2025-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.